TWiV 704: COVID-19 clinical update #44 with Dr. Daniel Griffin
Jan 09, 2021•32 min•Ep. 704
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In this COVID-19 clinical update, Daniel Griffin summarizes current status of vaccination in the US, discusses a study on convalescent sera from Argentina, use of remdesivir in patients with kidney disease, and provides further considerations on the use of Ct values in patient management.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Argentine study on plasma therapy (NEJM)
- Ct values and clinical outcome (Open Forum Inf Dis)
- Bamlanivimab fact sheet (FDA pdf)
- Cognitive defects in recovered COVID-19 patients (medRxiv)
- Letters read on TWiV 704
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv
For the best experience, listen in Metacast app for iOS or Android